{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:15:48Z","timestamp":1770909348442,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,12]]},"DOI":"10.7759\/cureus.103470","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:13:16Z","timestamp":1770905596000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Long-Term Use of Isavuconazole in a Tacrolimus-Treated Japanese Kidney Transplant Recipient With Disseminated Cryptococcosis and Probable Invasive Aspergillosis"],"prefix":"10.7759","author":[{"given":"Yoshihiko","family":"Akagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanaka","family":"Egawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhisa","family":"Shinkai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinpei","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1086\/368091","article-title":"The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000","volume":"36","author":"Mirza SA","year":"2003","unstructured":"Mirza SA, Phelan M, Rimland D, et al.. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis. 2003, 36:789-94. 10.1086\/368091","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.3201\/eid0703.017302","article-title":"Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome","volume":"7","author":"Husain S","year":"2001","unstructured":"Husain S, Wagener MM, Singh N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis. 2001, 7:375.","journal-title":"Emerg Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00731-4","article-title":"Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM","volume":"24","author":"Chang CC","year":"2024","unstructured":"Chang CC, Harrison TS, Bicanic TA, et al.. Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM. Lancet Infect Dis. 2024, 24:e495-512. 10.1016\/S1473-3099(23)00731-4","journal-title":"Lancet Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson TF","year":"2016","unstructured":"Patterson TF, Thompson GR 3rd, Denning DW, et al.. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016, 63:e1-60. 10.1093\/cid\/ciw326","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13510","article-title":"Interactions between anti-infective agents and immunosuppressants - Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Sparkes T","year":"2019","unstructured":"Sparkes T, Lemonovich TL. Interactions between anti-infective agents and immunosuppressants - Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019, 33:e13510. 10.1111\/ctr.13510","journal-title":"Clin Transplant"},{"key":"ref6","article-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard - Third Edition","author":"Rex JH","year":"2008","unstructured":"Rex JH. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard - Third Edition. Clinical and Laboratory Standards Institute, Wayne, PA; 2008."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw B","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, et al.. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008, 46:1813-21. 10.1086\/588660","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/Msgerc definitions of invasive fungal diseases: summary of activities of the Intensive Care Unit Working Group","volume":"72","author":"Bassetti M","year":"2021","unstructured":"Bassetti M, Azoulay E, Kullberg BJ, et al.. EORTC\/Msgerc definitions of invasive fungal diseases: summary of activities of the Intensive Care Unit Working Group. Clin Infect Dis. 2021, 72:S121-7. 10.1093\/cid\/ciaa1751","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-019-03469-3","article-title":"Clinical features and cause analysis of false positive results of Aspergillus galactomannan assay in pulmonary cryptococcosis patients","volume":"38","author":"Takazono T","year":"2019","unstructured":"Takazono T, Saijo T, Ashizawa N, et al.. Clinical features and cause analysis of false positive results of Aspergillus galactomannan assay in pulmonary cryptococcosis patients. Eur J Clin Microbiol Infect Dis. 2019, 38:735-41. 10.1007\/s10096-019-03469-3","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2022.10.010","article-title":"Efficacy and safety of isavuconazole against deep-seated mycoses: a phase 3, randomized, open-label study in Japan","volume":"29","author":"Kohno S","year":"2023","unstructured":"Kohno S, Izumikawa K, Takazono T, et al.. Efficacy and safety of isavuconazole against deep-seated mycoses: a phase 3, randomized, open-label study in Japan. J Infect Chemother. 2023, 29:163-70. 10.1016\/j.jiac.2022.10.010","journal-title":"J Infect Chemother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-10627-w","article-title":"Efficacy and safety of isavuconazole versus voriconazole for the treatment of invasive fungal infections: a meta-analysis with trial sequential analysis","volume":"25","author":"Weng J","year":"2025","unstructured":"Weng J, Du X, Fang B, Li Y, Huang L, Ju Y. Efficacy and safety of isavuconazole versus voriconazole for the treatment of invasive fungal infections: a meta-analysis with trial sequential analysis. BMC Infect Dis. 2025, 25:230. 10.1186\/s12879-025-10627-w","journal-title":"BMC Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13622","article-title":"A systematic review and meta-analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections","volume":"66","author":"Kato H","year":"2023","unstructured":"Kato H, Hagihara M, Asai N, et al.. A systematic review and meta-analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections. Mycoses. 2023, 66:815-24. 10.1111\/myc.13622","journal-title":"Mycoses"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2024.10.002","article-title":"Successful treatment of disseminated cryptococcosis with liposomal amphotericin B and isavuconazole in an adult living with HIV: a case report and literature review","volume":"31","author":"Kawaguchi T","year":"2025","unstructured":"Kawaguchi T, Kitamura A, Kimura M, et al.. Successful treatment of disseminated cryptococcosis with liposomal amphotericin B and isavuconazole in an adult living with HIV: a case report and literature review. J Infect Chemother. 2025, 31:102534. 10.1016\/j.jiac.2024.10.002","journal-title":"J Infect Chemother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir969","article-title":"Administration of voriconazole in patients with renal dysfunction","volume":"54","author":"Neofytos D","year":"2012","unstructured":"Neofytos D, Lombardi LR, Shields RK, et al.. Administration of voriconazole in patients with renal dysfunction. Clin Infect Dis. 2012, 54:913-21. 10.1093\/cid\/cir969","journal-title":"Clin Infect Dis"},{"key":"ref15","article-title":"Isavuconazole treatment of cryptococcosis and dimorphic mycoses","volume":"63","author":"Thompson GR 3rd","year":"2016","unstructured":"Thompson GR 3rd, Rendon A, Ribeiro Dos Santos R, et al.. Isavuconazole treatment of cryptococcosis and dimorphic mycoses. Clin Infect Dis. 2016, 63:356-62.","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/454473-successful-long-term-use-of-isavuconazole-in-a-tacrolimus-treated-japanese-kidney-transplant-recipient-with-disseminated-cryptococcosis-and-probable-invasive-aspergillosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:13:16Z","timestamp":1770905596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/454473-successful-long-term-use-of-isavuconazole-in-a-tacrolimus-treated-japanese-kidney-transplant-recipient-with-disseminated-cryptococcosis-and-probable-invasive-aspergillosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.103470","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,12]]}}}